Skip to content
Open access

Induction of S100A11 calcium-binding protein in renal tubular epithelial cells during the formation of calcium oxalate crystals.

2026 · Journal of Toxicological Sciences · Vol 51 9, pp. 489-500 · 0 citations
Medicine

TL;DR

The possibility that, in addition to annexin family proteins, S100 family proteins might be involved in the regulation of CaOx crystal formation and/or other events associated with crystal formation is presented.

Abstract

Acute kidney injuries and renal dysfunction caused by ethylene glycol poisoning are often associated with nephrolithiasis. Calcium oxalate (CaOx) crystal formation is considered one of the most common events at the early stage of nephrolithiasis. The aim of this study is to investigate molecular mechanisms underlying CaOx crystal formation on renal tubular epithelial cells in vitro. We applied oxalate or potassium oxalate (final concentrations, 200-1200 µM) in the medium culturing NRK-52E rat proximal tubular epithelial cells. Cell death was observed with levels of oxalate or potassium oxalate above 800 µM 48 hr after addition. Crystals, mainly consisting of CaOx as confirmed by polarized light microscopy, were detected on cells treated with 800 µM oxalate or potassium oxalate. Transcriptome analysis showed that a gene (S100A11-like) belonging to the S100 family, which consists of homologous Ca-binding proteins, many of which can form complexes with annexin family proteins, was the gene most upregulated by 800 µM oxalate. Immunoblot as well as immunocytochemical analysis indicated not only upregulation but also alteration of intracellular localization of S100A11. The same altered pattern of localization was also observed for annexin A2, which has been shown to be involved in the formation of CaOx crystals. This study presents the possibility that, in addition to annexin family proteins, S100 family proteins might be involved in the regulation of CaOx crystal formation and/or other events associated with crystal formation.

Read PDF

Similar papers

Oct 2026

B-279 Differentiation of urinary biomarkers in idiopathic calcium oxalate stone disease

Acidic matrix macromolecules, widely distributed across mineralized tissues, are believed to play a critical role in regulating crystal formation. The present study investigates key urinary biomarkers in both patients with idiopathic renal calcium stones and healthy controls, focusing on their influence on crysta...

M. Gohel · 0 citations
Open access Aug 2026

Systematic characterizations of a urinary protein, prosaposin, as a novel inhibitor of calcium oxalate stone formation.

The development of calcium oxalate (CaOx) stones in the kidney comprises multiple processes involving sophisticated interactions between stone minerals and other molecules, especially urinary proteins. Prosaposin (PSAP) has recently been identified in the urine from healthy (non-stone) subjects, not in the urine from C...

Sunisa Yoodee, Yanisa Suebsuk, Sirikanya Plumworasawat et al. · 0 citations
Open access Oct 2026

Acacetin alleviates pyroptosis, inflammatory response, and oxidative stress in renal tubular epithelial cells caused by kidney stone via targeting GPR35.

Nephrolithiasis, particularly calcium oxalate (CaOx) stones, remains a global health burden with limited pharmacological options for recurrence prevention. In this study, we investigated the therapeutic mechanism of acacetin (ACA) using both in vitro (COM-stimulated HK-2 cells) and in vivo (glyoxylate-induced mice) mod...

Lei Jiang, Qing-Yan Xia, Zhong-Wen Hong et al. · 0 citations
Sep 2026

β-carotene attenuates calcium oxalate crystal-induced renal injury through suppression of NF-κB-mediated inflammation

Findings indicate that β-carotene ameliorates CaOx crystal-induced renal injury and inflammation, at least in part through suppression of NF-κB signaling, and may offer a potential basis for the development of novel preventive and therapeutic approaches for kidney stone disease.

Ming-Qin Su, Yu-Xiang Guan, Hong-Quan Wei et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.